Serum Institute

SII's free supply of Covishield to Centre: First lot of 80 lakh doses set for dispatch

Since the launch of the anti-Covid vaccination drive, SII has so far provided 170 crore doses of Covishield to the government.

published on : 14th January 2023

COVID-19: Covovax to get approval as booster in 10-15 days, says SII CEO Adar Poonawalla 

Covovax works very well against omicron variant,more than Covishield, says Adar Poonawalla.

published on : 9th January 2023

Posing as Adar Poonawalla, scammers dupe SII of Rs 1 cr; 7 nabbed

A complaint in this regard was registered and during the investigation, police zeroed in on the eight accounts to which the money was transferred.

published on : 26th November 2022

SII stopped Covishield production in Dec 2021; Poonawalla; claims are no takers for booster shots 

The SII had announced its partnership with Oxford University to manufacture the vaccine in April 2020.

published on : 20th October 2022

Fraudsters dupe Serum Institute of Rs 1 crore by asking for money transfer in CEO's name

The fraud unfolded between the afternoons of Wednesday and Thursday, said an official of Bundgarden police station.

published on : 10th September 2022

Bombay HC issues notice to Central govt, Serum Institute over plea on alleged Covid vaccine death

Dilip Lunawat in his petition blamed the authorities for creating alleged false narratives and misrepresentations about the Coronavirus vaccine.

published on : 3rd September 2022

India's first vaccine against cervical cancer to launch on September 1

The most awaited vaccine will be launched by the Union Minister of State (Independent Charge) Science & Technology Jitendra Singh on September 1.

published on : 31st August 2022

Odisha to introduce HPV vax in 10 aspirational districts in the first phase

The State government has also decided to expand screening and services for breast and cervical cancers from medical colleges to the district headquarters hospital (DHH).

published on : 15th August 2022

Drug controller allows sale of Serum Institute’s cervical cancer vaccine

The DCGI’s approval came following a recommendation by the Subject Expert Committee (SEC) on Covid-19 of the CDSCO on June 15.

published on : 13th July 2022

SII seeks nod to export 32.4 lakh doses of its Covid vaccine Covovax to US

The sources said it will be the first instance of any Indian manufacturer's vaccine -- Covid or non-Covid -- to be exported to the US.

published on : 30th June 2022

NTAGI to review trial data on Serum Institute's qHPV vaccine against cervical cancer

A separate HPV working group of the National Technical Advisory Group on Immunisation (NTAGI) had examined on June 8 the clinical trial data and usefulness of the vaccine.

published on : 26th June 2022

Panel for emergency use approval to SII vaccination for 7-11 age group

Officials said the Subject Expert Committee deliberated upon the matter and recommended EUA for use in younger children.

published on : 25th June 2022

Government panel recommends emergency approval for SII's Covovax for 7-11 year olds

The DCGI had approved Covovax for restricted use in emergency situations in adults on December 28 and in the 12 to 17 years age group subject to certain conditions on March 9.

published on : 24th June 2022

Government panel recommends market authorisation for SII's qHPV vaccine against cervical cancer

In the application, Singh is learnt to have stated that qHPV vaccine CERVAVAC has demonstrated robust antibody response that is nearly 1,000 times higher than the baseline.

published on : 15th June 2022

Serum Institute, Symbiosis to set up research centre for vaccine development

The entity will work towards improving health equity against future pandemics and infectious diseases. It will also ensure cross-programme coordination and collaboration.

published on : 13th May 2022

Millions of COVID vaccines unsold; stopped production since December 2021: Adar Poonawalla

He also called for speeding up the decision to vaccinate young kids and said if they can be given other immunisation vaccines why not for the COVID-19.

published on : 22nd April 2022

Poonawalla warns against return to business-as-usual approach 

Calling for increased adoption of booster doses, Poonawalla said it is also needed because people need to travel internally and outside,  many countries have made booster doses mandatory for travel.

published on : 22nd April 2022

Panel seeks more data on Serum Institute's EUA application for Covovax use

The SII had last month submitted an application to the Drugs Controller General of India (DCGI) seeking emergency use authorisation (EUA) for Covovax's use among children in the age group.

published on : 12th April 2022

Serum Institute to give free Covishield vials to private vaccination centres to compensate for price difference

India began administering the precaution dose of COVID-19 vaccines to all beneficiaries aged above 18 years at private vaccination centres from Sunday.

published on : 10th April 2022

Covishield & Covaxin prices cut, hospitals to pay Rs 225 per dose

The precautionary dose has to be of the same vaccine used for the first two doses.

published on : 10th April 2022
1 2 >